NEUBIE
Commercial- Indications
- Neuropathy, Multiple sclerosis, Chronic pain, Orthopedic injuries, Neurological injuries
Company intelligence / Profile preview
Clinical studies and real-world use have shown that the NEUBIE device improves chronic and acute pain, range of motion, muscle activation, and quality of life for patients with orthopedic injuries, neurological conditions, or post-surgical needs. Peer-reviewed research indicates similar efficacy to traditional high-load resistance training but with less strain on the body. The device is FDA-cleared for multiple indications including neuromuscular reeducation and chronic/acute pain management.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NeuFit.